BioCatalystWatch
KLRSWorkspace / KLRS / OverviewCompany library
Kalaris Therapeutics, Inc. logo

Kalaris Therapeutics, Inc.

Kalaris Therapeutics, Inc. (KLRS)

Website

Price
Market cap
Next catalystExpected 2H 2027TH103 · Phase 1/2 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

TH103

VEGF-A × VEGF-B × PlGF × HSPG

PreINDP1P2FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

TH103

VEGF-A × VEGF-B × PlGF × HSPG

PreINDP1P2FilingApproved
Upcoming / outlook

Other pipelines

TH103

VEGF-A × VEGF-B × PlGF × HSPG

TH103

VEGF-A × VEGF-B × PlGF × HSPG

TH103

VEGF-A × VEGF-B × PlGF × HSPG

TH103

VEGF-A × VEGF-B × PlGF × HSPG

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

KLRS PR & News

PR & News

KLRS SEC archive